Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
Recruiting · NCT06296550 · Interventional (participants receive a specific treatment) · Lead sponsor: Scripps Whittier Diabetes Institute
View the official record on ClinicalTrials.gov →Interventions studied
CGM DeviceDulce Digital Text Messaging Intervention
What this trial is about
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosed with type 2 diabetes
- Are not currently using a CGM
- Are not using insulin therapies
- Speak English, Spanish or Arabic
- Have A1c between 7.5% and 12.0% in last 90 days
- Have a cellphone that can receive/send text messages and counts steps
Exclusion criteria
- Are using insulin therapies
- Are pregnant
- Are currently using a CGM
- Are currently participating in another diabetes-related study
Where it is running
1 location listed across 1 US state.
- Scripps Whittier Diabetes Institute - San Diego, California, United States